Candel Therapeutics Inc. (CADL)
NASDAQ · Healthcare
Candel Therapeutics Inc. Operating Income 2020–2022
Candel Therapeutics Inc. annual/quarterly operating income history and growth rate from 2020 to 2022. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Candel Therapeutics Inc. operating income for the quarter ending September 30, 2022 was -8.9 M, a 10.61% increase year-over-year.
- Candel Therapeutics Inc. operating income for the twelve months ending September 30, 2022 was -34.6 M, a 126.08% increase year-over-year.
- Candel Therapeutics Inc. annual operating income for 2022 was -34.7 M, a 34.97% increase from 2021.
- Candel Therapeutics Inc. annual operating income for 2021 was -25.7 M, a 86.29% increase from 2020.
- Candel Therapeutics Inc. annual operating income for 2020 was -13.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Candel Therapeutics Inc. Operating Income — FAQ
Candel Therapeutics Inc. (CADL) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Candel Therapeutics Inc.'s operating income?
Candel Therapeutics Inc. (CADL) reported operating income of -$35M for fiscal 2022.
Where can I see CADL's operating income history?
The chart and table above show Candel Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.